Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Phone calls could save lives: new study tests vaccine reminders for displaced kids

NCT ID NCT07154836

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether automated phone call reminders can help increase childhood vaccination rates among internally displaced families in Borno State, Nigeria. About 366 caregivers of young children will receive regular calls with reminders and health info in local languages. Researchers will measure how many children get vaccinated and how well the system works in a conflict-affected, low-resource setting.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Telephone call reminders (Call4life platform)
What this could lead to
If it works, this could provide a low-cost way to increase vaccination coverage in hard-to-reach, conflict-affected areas.
What could go wrong
This is a small feasibility study, not a large trial. Results may not apply to other settings, and phone access or network issues could limit effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 366 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

23 to 23 months

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * • Caregivers (male/female) of children from 0-23 months of age or pregnant women in third trimester * Caregivers above the age of 18 years of age * Caregivers who consent to participate in the study. * Resident in the IDP camp for at least one year Exclusion Criteria: * • Pregnant women in third trimester in first pregnancy (primigravida) * Caregivers that are temporary residents of the IDP camps (IDPs on transit or visitors) * Caregivers without the mental capacity to comprehend the questions asked. * Inability to use or interact with a mobile phone ( e.g. those with hearing defects or poor vision)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Access to immunization are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • El Miskin

    Jere, Borno State, Nigeria